Summary The Second Meeting of the British Society for Immunology Tumour Immunology Affinity Group (TIAG) took place at King's College (London, UK) on 17-18 June 1997 and brought together over 100 tumour immunologists from the UK and abroad. In contrast to previous meetings the focus of the meeting was on the role of adhesion in immunosurveillance and tumour dissemination. In addition, recent achievements in the areas of chemokines, cytotoxic T-lymphocyte (CTL) and natural killer (NK) cells, co-stimulation, gene and adoptive immunotherapy were also addressed. The purpose of this report is to outline current trends in tumour immunology.Keywords: gene and adoptive cancer immunotherapy; cell adhesion; chemotaxis; apoptosis; natural killer cells
ADHESION AND CHEMOTAXISThe conference began with an overview of cell adhesion molecules in the interaction of leucocyte and tumour cells with the endothelium (Dr N Hogg, London, UK). Well-known adhesive ligands were described including PSGL-1 (a ligand for all three selectins, especially relevant for neutrophil adhesion), CD44 [as a rolling receptor for haematopoietic (DeGrendele et al, 1996) and potentially non-haematopoietic cells, such as pancreatic carcinoma and melanoma] and a4p1 (adherence receptor for leucocytes and tumour cells) ( Figure 1). The role of cell adhesion in leucocyte activation ('in/out' signalling) was also highlighted. Furthermore, chemokines, with few exceptions (Szabo et al, 1997), appear unable to activate adhesion molecules (such as LFA-1) on nonprimed T lymphocytes, as 'naive' T cells do not express corresponding chemokine receptors. However, the adhesion molecules on activated leucocytes can be 'switched on' if chemokine receptors are cross-linked (e.g. the cross-linking of IL-8 receptors by IL-8 bound to extracellular matrix proteins). N Hogg also discussed the ability of the a4,Bl integrin complex to either facilitate (Matsuura et al, 1996) or inhibit (Qian et al, 1994) the metastasis of neoplastic cells by decreasing the invasive potential of melanoma and even by inducing apoptosis of lymphoma cells (if expressed in situ). Furthermore, additional studies described the ability of the metalloproteinase MMP2 to form a complex with aVP3 integrin (vitronectin R) (Brooks et al, 1996) and facilitate melanoma cell migration through its ability to digest collagen, unveiling its hidden RGD sequence and thus permitting integrin-mediated adhesion. In another model, the urokinase-type plasminogen activator receptor (uPAR) forms a complex with active integrins, which has the effect of destabilizing integrin adhesion and promoting adhesion and migration on vitronectin, thus potentially enhancing the invasive properties of tumour cells (Wei et al, 1996).The adhesion and trafficking mechanisms of lymphocyte transmigration in both normal and adjacent tumour endothelium remain poorly understood. In an elegant in vivo model using a mouse cremaster muscle implanted with a tumour and fluorescent confocal microscopy, murine lymphocytes were examined for their ability...